| Long name: |
DR alpha chain (HLA-DRA), Recombinant Human HLA class II histocompatibility antigen |
| Alternative names: |
DR alpha, DR alpha chain, DR alpha chain, DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen, MHC cell surface glycoprotein, MHC class II antigen DRA, MHC class II antigen DRA, class II, histocompatibility antigen HLA-DR alpha, major histocompatibility complex, HLA class II histocompatibility antigen |
| Gene name: |
HLA-DRA |
| Other gene names: |
HLA-DRA, HLA-DRA1, HLA-DRA1, MLRW, HLA-DRA |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, DR alpha chain (HLA-DRA) is a recombinant protein expressed in E, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, HLA class II histocompatibility antigen |
| Product category: |
Recombinant Proteins |
| Expression system: |
coli, E |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Description: |
Antigens are peptides or recombinant or native dependent on the production method |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
HLA class II histocompatibility DR alpha chain (HLA-DRA) |
| Short name: |
DR alpha chain (HLA-DRA), HLA class II histocompatibility antigen |
| Technique: |
antigenes, antigen |
| Species: |
Humans, Human |
| Alternative name: |
DR a epitope (major histocompatibility aggregate, DR a), class II, sapiens Human leukocyte antigen class II histocompatibility protein, H |
| Alternative technique: |
antigenes |
| Alternative to gene target: |
BOLA-DRA and IDBG-632808 and ENSBTAG00000010645 and 506214, Cell surfaces, DR alpha, HLA-DRA and IDBG-80796 and ENSG00000204287 and 3122, HLA-DRA1 and MLRW, class II, peptide antigen binding, this GO :0000139 and this GO lgi membrane and cellular component this GO :0002503 and peptide antigen assembly with MHC class II protein complex and biological process this GO :0002504 and antigen processing and presentation of peptide or polysaccharide antigen via MHC class II and biological process this GO :0002506 and polysaccharide assembly with MHC class II protein complex and biological process this GO :0005515 and protein binding and molecular function this GO :0005764 and lysosome and cellular component this GO :0005765 and lysosomal membrane and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006955 and immune response and biological process this GO :0009986 and cell surface and cellular component this GO :0012507 and ER to this GO lgi transport vesicle membrane and cellular component this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019221 and cytokine-mediated signaling pathway and biological process this GO :0019882 and antigen processing and presentation and biological process this GO :0019886 and antigen processing and presentation of exogenous peptide antigen via MHC class II and biological process this GO :0023026 and MHC class II protein complex binding and molecular function this GO :0030658 and transport vesicle membrane and cellular component this GO :0030666 and endocytic vesicle membrane and cellular component this GO :0030669 and clathrin-coated endocytic vesicle membrane and cellular component this GO :0031295 and T cell costimulation and biological process this GO :0031902 and late endosome membrane and cellular component this GO :0032395 and MHC class II receptor activity and molecular function this GO :0032588 and trans- this GO lgi network membrane and cellular component this GO :0042605 and peptide antigen binding and molecular function this GO :0042613 and MHC class II protein complex and cellular component this GO :0050852 and T cell receptor signaling pathway and biological process this GO :0050890 and cognition and biological process this GO :0060333 and interferon-gamma-mediated signaling pathway and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0071556 and integral component of lumenal side of endoplasmic reticulum membrane and cellular component, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0023026 : MHC class II protein complex binding and also this GO :0032395 : MHC class II receptor activity and also this GO :0042605 : peptide antigen binding, this GO :0023026 : MHC class II protein complex binding, this GO :0032395 : MHC class II receptor activity, this GO :0042605 : peptide antigen binding, major histocompatibility complex |
| Identity: |
4947 |
| Gene: |
HLA-DRA |
More about : HLA-DRA |
| Long gene name: |
DR alpha , class II, major histocompatibility complex |
| Synonyms gene: |
HLA-DRA1 |
| Locus: |
6p21, 32 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
3122 |
| RefSeq identity: |
NM_019111 |
| Classification: |
C1-set domain containing Histocompatibility complex |
| Havana BLAST/BLAT: |
OTTHUMG00000031269 |
| Locus Specific Databases: |
IMGT/HLA Database |